Business Wire

Adva Network Security scores world first with BSI-approved 400G encryption solution

25.9.2025 09:00:00 CEST | Business Wire | Press Release

Share

Adva Network Security today announced that its FSP 3000 S-Flex™ 400Gbit/s solution has achieved a world first with approval from the German Federal Office for Information Security (BSI) for the transportation of data classified as Verschlusssache – Nur für den Dienstgebrauch (VS-NfD) – “For Official Use Only” – and EU/NATO “Restricted.” No other 400Gbit/s solution on the market has earned this level of accreditation. Leveraging Adva Network Security’s ConnectGuard™ technology, it delivers quantum-safe Layer 1 encryption with post‑quantum cryptography (PQC), offering future-ready protection for sensitive data. By deploying S-Flex™, authorities, critical infrastructure operators and high‑security enterprises can defend against a range of threats, including harvest-now, decrypt-later attacks.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250922296544/en/

Adva Network Security’s FSP 3000 S-Flex™ with BSI-approved 400Gbit/s encryption marks a major milestone for safeguarding Europe’s digital future.

“The European Union urgently needs to advance its position on post-quantum cryptography to combat long-term threats to sensitive and classified data. With our FSP 3000 S-Flex™, we’ve moved beyond roadmap promises to deliver the world’s first 400Gbit/s Layer 1 encryption solution approved by the BSI for VS-NfD and EU/NATO-restricted data,” said Josef Sißmeir, GM of Adva Network Security. “This is a significant step in securing Europe’s digital future. While post-quantum policy is still being debated in boardrooms and committees, we’re already helping protect data center operators, financial institutions and defense agencies from quantum-enabled threats. BSI-approved and built for the future, our technology doesn’t just meet critical security standards – it sets the benchmark for emerging ones.”

The FSP 3000 S-Flex™ combines BSI-approved Layer 1 encryption with post-quantum key exchange to protect classified data, including VS‑NfD and EU/NATO‑Restricted. Developed by Adva Network Security as a high-capacity transponder/muxponder card for the Adtran FSP 3000 open optical transport platform, it delivers ultra-low-latency connectivity with a high-density design. The solution supports Fibre Channel up to 64Gbit/s and Ethernet from 1GbE to 400GbE (1/10/25/100/400GbE), as well as IBM Z mainframe connectivity, multiplexing multiple client services into a single 400Gbit/s wavelength. As hosted data volumes grow, the technology ensures scalable bandwidth and quantum-safe encryption for enterprises, public authorities and operators of critical infrastructure.

“Harvest-now, decrypt-later attacks threaten the future security of data transmitted today, making post-quantum cryptography one of the most urgent priorities for guaranteeing the digital sovereignty of Europe,” commented Michael Roth, GM of Adva Network Security. “The European Commission has made clear that member states must coordinate their transition to PQC. With the FSP 3000 S-Flex™, we’re leading that objective. As the industry’s first 400Gbit/s Layer 1 encryption solution approved by the BSI for VS-NfD and EU/NATO-restricted data, our high-capacity card is already deployed and certified to protect the most sensitive information. It gives operators a path to upgrade in sync with evolving standards and higher data rates in step with national strategies, strengthening Europe’s digital transformation over the next decade.”

About Adva Network Security

Adva Network Security is a leading German IT-security company. We provide robust optical and Ethernet networking solutions and a comprehensive service offering. Our ConnectGuard™ technology delivers quantum-safe encryption that protects large-scale networks and essential applications. Critical infrastructure, government, defense and enterprise customers rely on our technical expertise in communication networks and information security. This unique combination of skills ensures the resilience and security of their essential IT and OT infrastructure. Customers can count on our services team from initial design to secure operation, ensuring business continuity amid growing cyber threats. Our design, manufacturing processes and security solutions are certified by leading government security agencies. For more information on how we can help you, please visit www.advasecurity.com.

Published by

Adva Network Security GmbH, Berlin, Germany

www.advasecurity.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20250922296544/en/

Contacts

For media
Antje Hartmann
t +49 30 2636969166
info@advasecurity.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye